Massmutual Trust »

Trevi Therapeutics shares owned by Massmutual Trust

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Massmutual Trust from 13F filings

Historical chart of Massmutual Trust investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Massmutual Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Massmutual Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.7k 516 9.15
2025-06-30 $2.9k 528 5.47

More positions owned by Massmutual Trust

NVIDIA Corp Common / Ordinary Stock (NVDA)
Microsoft Corp Common / Ordinary Stock (MSFT)
Apple Common / Ordinary Stock (AAPL)
Vanguard Mid-Cap ETF Exchange Traded Fund (VO)
Amazon.com Common / Ordinary Stock (AMZN)
Vanguard FTSE Developed Markets ETF Exchange Traded Fund (VEA)
JPMorgan Chase & Co Common / Ordinary Stock (JPM)
Alphabet Common / Ordinary Stock (GOOGL)
Meta Platforms Common / Ordinary Stock (META)
Broadcom Common / Ordinary Stock (AVGO)
Alphabet Common / Ordinary Stock (GOOG)
iShares MSCI EAFE ETF Exchange Traded Fund (EFA)
Dimensional US Small Cap ETF Exchange Traded Fund (DFAS)
Visa Common / Ordinary Stock (V)
Home Depot Inc/The Common / Ordinary Stock (HD)

View all positions for Massmutual Trust

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Viking Global Investors
Vivo Capital
Marshall Wace
Alliancebernstein
MPM Oncology Impact Management
OrbiMed Advisors
FMR
Wellington Management Company
Octagon Capital Advisors
Affinity Asset Advisors

View all funds holding Trevi Therapeutics